Clinical observation on Shensongyangxin capsule in treatment of senile ventricular premature beat
ZHANG Lili
HUANG Xiaowen
ZHAN Hongwei
ZHAO Wei
TIAN Hong
Abstract：Objective To observe the therapeutic effect and safety of Shensongyangxin capsule on senile arrhythmia. Methods 132 cases of elderly (>65 years old) in patients with coronary heart disease and ventricular premature beat (>30 h-1), were randomly divided into 2 groups: propafenone in the treatment group (64 cases), Shensongyangxin capsule treatment group (68 cases). The treatment course was 8 weeks, before and after the treatment of 24 h dynamic electrocardiogram room prematurenumber. The number of dynamic ECG beats was 50% reduction for clinical improvement. Results The total effective rate of Premature ventricular contractions in treatment group was 88.2%, which was 73.5% in control group. There was a significant difference between two groups (χ2=6.810,P<0.05). The total effective rate of clinal symptoms in treatment group was 89.7%, which was 76.6% in control group. There was a significant difference between two groups (χ2=7.030,P<0.05). Conclusion Shensongyangxin capsule combined with western drugs is safe, simple and effective in treating semile ventricular premature beat caused by coronary atherosclerotic heart disease.
Keywords：Ventricular premature beatCoronary heart diseaseShensongyangxin capsule
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 49-51 )